HNF1 β/TCF2 mutations impair transactivation potential through altered co-regulator recruitment
Open Access
- 15 December 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 13 (24) , 3139-3149
- https://doi.org/10.1093/hmg/ddh338
Abstract
Mutations in the HNF1β gene, encoding the dimeric POU-homeodomain transcription factor HNF1β (TCF2 or vHNF1), cause various phenotypes including maturity onset diabetes of the young 5 (MODY5), and abnormalities in kidney, pancreas and genital tract development. To gain insight into the molecular mechanisms underlying these phenotypes and into the structure of HNF1β, we functionally characterized eight disease-causing mutations predicted to produce protein truncations, amino acids substitutions or frameshift deletions in different domains of the protein. Truncated mutations, retaining the dimerization domain, displayed defective nuclear localization and weak dominant-negative activity when co-expressed with the wild-type protein. A frameshift mutation located within the C-terminal QSP-rich domain partially reduced transcriptional activity, whereas selective deletion of this domain abolished transactivation. All five missense mutations, which concern POU-specific and homeodomain residues, were correctly expressed and localized to the nucleus. Although having different effects on DNA-binding capacity, which ranged from complete loss to a mild reduction, these mutations exhibited a severe reduction in their transactivation capacity. The transcriptional impairment of those mutants, whose DNA-binding activity was weakly or not affected, correlated with the loss of association with one of the histone-acetyltransferases CBP or PCAF. In contrast to wild-type HNF1β, whose transactivation potential depends on the synergistic action of CBP and PCAF, the activity of these mutants was not increased by the synergistic action of these two coactivators or by treatment with the specific histone-deacetylase inhibitor TSA. Our findings suggest that the complex syndrome associated with HNF1β-MODY5 mutations arise from either defective DNA-binding or transactivation function through impaired coactivator recruitment.Keywords
This publication has 39 references indexed in Scilit:
- Transcriptional networks controlling pancreatic development and beta cell functionDiabetologia, 2004
- Control of Pancreas and Liver Gene Expression by HNF Transcription FactorsScience, 2004
- Distinct Molecular and Morphogenetic Properties of Mutations in the Human HNF1β Gene That Lead to Defective Kidney DevelopmentJournal of the American Society of Nephrology, 2003
- Diabetes Mutations Delineate an Atypical POU Domain in HNF-1αMolecular Cell, 2002
- Splice site mutation in the hepatocyte nuclear factor-1β Gene, IVS2nt + 1G > A, associated with maturity-onset diabetes of the young, renal dysplasia and bicornuate uterusDiabetologia, 2001
- Acetylation Regulates Transcription Factor Activity at Multiple LevelsMolecular Cell, 2000
- Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1β1Kidney International, 2000
- Anatomy of a Homeoprotein Revealed by the Analysis of Human MODY3 MutationsPublished by Elsevier ,1999
- A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1betaHuman Molecular Genetics, 1999
- A Bipartite Activation Domain Is Responsible for the Activity of Transcription Factor HNF1/LFB1 in Cells of Hepatic and Nonhepatic OriginDNA and Cell Biology, 1993